Erika Reategui

Vice President, Operations and Compliance

Erika is a highly experienced Molecular Biologist with a remarkable track record of over 25 years in clinical research, with several certifications as a Clinical Research Professional, Certified Community Health Worker, and Certified Clinical Research Contract Professional. With a strong background in regulatory environments, including FDA, MHRA, Health Canada, and EMA, Erika has consistently demonstrated exceptional expertise and knowledge in navigating the complex landscape of clinical trials, regulatory compliance, and drug development.

Throughout her career, she has focused on head and neck cancer research and early detection testing, accumulating over 13 years of experience in this field. In addition to her expertise in head and neck cancer research, Erika has extensive experience in early-phase and late-phase environments, including both GLP (Good Laboratory Practice) and GCP (Good Clinical Practice) environments. This expertise ensures that all research activities adhere to rigorous quality standards and regulatory requirements, guaranteeing the integrity and reliability of the data generated.

Erika also possesses a deep understanding of GMP (Good Manufacturing Practice) and GVP (Good Pharmacovigilance Practices) principles, acquired through four years of experience in these areas. This knowledge enables her to effectively collaborate with manufacturing teams and monitor the safety of medicines to ensure the production of high-quality and compliant pharmaceutical products.

Throughout her career, Erika has made significant contributions to the field of molecular biology and clinical research. She has authored numerous publications in peer-reviewed journals and has presented her research and findings at international conferences as an expert in the field.